Cipher Pharmaceuticals Inc (NASDAQ: CPHR)
Cipher Pharmaceuticals was off to a relatively normal start to the day today. However, minutes ago, we noticed a large spike on the stock followed by the shares being halted. With a little digging, we’ve figured out what’s going on. Below, we’ll talk about what we’re seeing from the stock, why, and what you should watch for with regard to CPHR next.
What’s Going On With CPHR?
As mentioned above, Cipher Pharmaceuticals was off to a relatively normal start to the trading session today. However, minutes ago, we started to see a large spike in the value of the stock. In the past 10 minutes, the stock has climbed more than 15%. Currently (11:27), CPHR is trading at $4.10 after a gain of $0.61, or 17.51%.
Why The Gains Are Happening
As soon as we noticed the spike, the CNA Finance team started to investigate, looking for a cause. According to recent reports, CPHR has hired an advisor to assist in finding strategic alternatives. In many cases, this could mean that an acquisition is on the horizon, and in just about all cases, it means that we can expect to see positive news ahead.
What Investors Should Be Watching For Ahead
Moving forward, investors should keep a close eye on what’s going on with the reports surrounding Cipher Pharmaceuticals. Exploring strategic alternatives is usually a good thing. However, we don’t know exactly what that means until we get more updates from the company. So, keep your eyes peeled for updates from CPHR that could lead to big movement.
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!
[Image Courtesy of Wikipedia]